Literature DB >> 10351126

Characterization of heparin aerosols generated in jet and ultrasonic nebulizers.

K E Bendstrup1, M T Newhouse, O F Pedersen, J I Jensen.   

Abstract

Inhaled heparin has been used for asthma treatment, but results have been inconsistent, probably due to highly varying lung doses. We determined the output per unit time and the particle size distributions of sodium heparin, calcium heparin, and low molecular weight (LMW) heparin formulations in five concentrations from Sidestream jet nebulizers (Medic-Aid, Bognor Regis, England) and an Ultraneb 2000 ultrasonic nebulizer (DeVilbiss, Langen, Germany). We also determined the inhaled mass and the estimated respirable mass for some combinations. For the jet nebulizer, output per minute increased with increasing concentration and flow rate, and particle size decreased from 3.64 to 2.01 microns (mass median diameter [MMD]). The percentage of particles less than 3 microns ranged from 41% to 74%. For the ultrasonic nebulizer, maximum output per minute was achieved at a concentration of 7000 i.u./mL; this maximum depended upon the viscosity and temperature of the solution. MMD was independent of formulation, temperature, or concentration and ranged from 5.61 to 7.03 microns. Sodium heparin/calcium heparin in a concentration of 20,000 i.u./mL in the jet nebulizer driven at 10 L/min produced the highest dose of heparin capable of reaching the lower respiratory tract. Mass balance was determined for these combinations with the jet nebulizer run until visible aerosol generation ceased. Of a loading dose of 80,000 i.u. of heparin, 45,000 i.u. remained in the dead space of the nebulizer, 20,000 i.u. was deposited on the exhalation filter, and 15,000 i.u. was captured on the inhalation filter (inhaled mass). This corresponds to a respirable mass of 10,000 i.u. of heparin with a high probability of reaching the lower respiratory tract in normal healthy adults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10351126     DOI: 10.1089/jam.1999.12.17

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  3 in total

Review 1.  Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis.

Authors:  Gerie J Glas; Ary Serpa Neto; Janneke Horn; Amalia Cochran; Barry Dixon; Elamin M Elamin; Iris Faraklas; Sharmila Dissanaike; Andrew C Miller; Marcus J Schultz
Journal:  Ann Intensive Care       Date:  2016-04-16       Impact factor: 6.925

2.  A Pilot Study of Nebulized Heparin for Prevention of Ventilator Induced Lung Injury: Comparative Effects with an Inhaled Corticosteroid.

Authors:  Farzin Ghiasi; Mohsen Sadeghian; Mohammad Emami; Babak Ali Kiaie; Sarah Mousavi
Journal:  Indian J Crit Care Med       Date:  2017-10

Review 3.  Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review.

Authors:  Nicholas Kipshidze; Patrick Iversen; Thomas R Porter; Nodar Kipshidze; Fakiha Siddiqui; George Dangas; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.